{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:16:52Z","timestamp":1790709412255,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health & Welfare","doi-asserted-by":"publisher","award":["HI18C1392"],"award-info":[{"award-number":["HI18C1392"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea Institute of Drug Safety and Risk Management"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.anai.2019.05.007","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T20:59:50Z","timestamp":1558126790000},"page":"48-56.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Breakthrough reactions during rapid drug desensitization: Clinical outcome and risk factors"],"prefix":"10.1016","volume":"123","author":[{"given":"Yewon","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oh Young","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heewon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minkyoung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hyang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha-Kyeong","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Jung","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyouk-Soo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You Sook","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Bom","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Bum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2019.05.007_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.mcna.2005.08.010","article-title":"Drug hypersensitivity","volume":"90","author":"Solensky","year":"2006","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.anai.2019.05.007_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1756-9966-30-93","article-title":"Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS","volume":"30","author":"Kadoyama","year":"2011","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.anai.2019.05.007_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1081-1206(10)60078-6","article-title":"Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents","volume":"102","author":"Lee","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2019.05.007_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/gyno.1994.1098","article-title":"Death from anaphylaxis to cisplatin: a case report","volume":"53","author":"Zweizig","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.anai.2019.05.007_bib5","first-page":"72","article-title":"Rapid drug desensitization for hypersensitivity reactions to chemotherapy and monoclonal antibodies in the 21st century","volume":"24","author":"Castells Guitart","year":"2014","journal-title":"J\u00a0Invest Allergol Clin Immunol"},{"key":"10.1016\/j.anai.2019.05.007_bib6","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1398-9995.2010.02441.x","article-title":"General considerations on rapid desensitization for drug hypersensitivity: a consensus statement","volume":"65","author":"Cernadas","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2019.05.007_bib7","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1365-2222.2011.03825.x","article-title":"Desensitization regimens for drug allergy: state of the art in the 21st century","volume":"41","author":"Liu","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2019.05.007_bib8","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jama.1947.72880350012008","article-title":"Successful desensitization in penicillin sensitivity","volume":"134","author":"Peck","year":"1947","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.anai.2019.05.007_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/01.all.0000235900.57182.15","article-title":"Rapid desensitization for hypersensitivity reactions to chemotherapy agents","volume":"6","author":"Castells","year":"2006","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.05.007_bib10","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2008.02.044","article-title":"Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases","volume":"122","author":"Castells","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.05.007_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","article-title":"Clinical features and severity grading of anaphylaxis","volume":"114","author":"Brown","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.05.007_bib12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/annonc\/mdg092","article-title":"Skin testing and hypersensitivity reactions to oxaliplatin","volume":"14","author":"Garufi","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anai.2019.05.007_bib13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ygyno.2004.08.002","article-title":"Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell\/IgE-mediated reactions","volume":"95","author":"Lee","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.anai.2019.05.007_bib14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ygyno.2005.06.028","article-title":"Rapid inpatient\/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses","volume":"99","author":"Lee","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.anai.2019.05.007_bib15","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jaci.2009.09.009","article-title":"Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment","volume":"124","author":"Brennan","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.05.007_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/1346-8138.12140","article-title":"Delayed mammalian meat-induced anaphylaxis confirmed by skin test to cetuximab","volume":"40","author":"Lee","year":"2013","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.anai.2019.05.007_bib17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12094-012-0909-9","article-title":"Effectiveness of oxaliplatin desensitization protocols","volume":"15","author":"Cortijo-Cascajares","year":"2013","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.anai.2019.05.007_bib18","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/imj.12320","article-title":"Treatment outcomes of rapid desensitisation protocols for chemotherapeutic agents and monoclonal antibodies following hypersensitivity reactions","volume":"44","author":"Kuo","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.anai.2019.05.007_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.18176\/jiaci.0070","article-title":"Experience with rapid desensitization to chemotherapy in a type B hospital","volume":"26","author":"Borras","year":"2016","journal-title":"J\u00a0Invest Allergol Clin Immunol"},{"key":"10.1016\/j.anai.2019.05.007_bib20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jaip.2015.12.019","article-title":"Safety, costs, and efficacy of rapid drug desensitizations to chemotherapy and monoclonal antibodies","volume":"4","author":"Sloane","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2019.05.007_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/1060028015625660","article-title":"Medication desensitization: characterization of outcomes and risk factors for reactions","volume":"50","author":"Murray","year":"2016","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.anai.2019.05.007_bib22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.anai.2018.01.008","article-title":"Skin testing and desensitization outcomes among platinum-sensitive oncology patients","volume":"120","author":"Mawhirt","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2019.05.007_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/207084","article-title":"Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review","volume":"2010","author":"Makrilia","year":"2010","journal-title":"Met Based Drugs"},{"key":"10.1016\/j.anai.2019.05.007_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaci.2018.02.018","article-title":"Hypersensitivity reactions to therapeutic monoclonal antibodies: phenotypes and endotypes","volume":"142","author":"Isabwe","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.05.007_bib25","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ygyno.2004.11.043","article-title":"Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments","volume":"96","author":"Feldweg","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.anai.2019.05.007_bib26","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1200\/JCO.1990.8.7.1263","article-title":"Hypersensitivity reactions from taxol","volume":"8","author":"Weiss","year":"1990","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.anai.2019.05.007_bib27","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jaip.2018.09.018","article-title":"Role of skin tests in the diagnosis of immediate hypersensitivity reactions to taxanes: results of a multicenter study","volume":"7","author":"Pagani","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2019.05.007_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaip.2013.08.011","article-title":"Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization","volume":"2","author":"Wong","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2019.05.007_bib29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1006\/gyno.2001.6331","article-title":"Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies","volume":"82","author":"Robinson","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.anai.2019.05.007_bib30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdj042","article-title":"Hypersensitivity reactions to oxaliplatin: experience in a single institute","volume":"17","author":"Siu","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anai.2019.05.007_bib31","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/eji.201040810","article-title":"Rapid IgE desensitization is antigen specific and impairs early and late mast cell responses targeting FcepsilonRI internalization","volume":"41","author":"Sancho-Serra Mdel","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.anai.2019.05.007_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000087355","article-title":"Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels","volume":"138","author":"Kepley","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.anai.2019.05.007_bib33","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1365-2222.2012.04013.x","article-title":"Subthreshold desensitization of human basophils re-capitulates the loss of Syk and FcepsilonRI expression characterized by other methods of desensitization","volume":"42","author":"MacGlashan","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2019.05.007_bib34","first-page":"108","article-title":"A\u00a0new rapid desensitization protocol for chemotherapy agents","volume":"21","author":"Gastaminza","year":"2011","journal-title":"J\u00a0Invest Allergol Clin Immunol"},{"key":"10.1016\/j.anai.2019.05.007_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/eci.11.75","article-title":"Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies","volume":"8","author":"Hong","year":"2012","journal-title":"Exp Rev Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2019.05.007_bib36","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.jaip.2017.11.033","article-title":"Outcome of 490 desensitizations to chemotherapy drugs with a rapid one-solution protocol","volume":"6","author":"Perez-Rodriguez","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120619303643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120619303643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:22:35Z","timestamp":1761052955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120619303643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1081120619303643"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2019.05.007","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breakthrough reactions during rapid drug desensitization: Clinical outcome and risk factors","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2019.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American College of Allergy, Asthma & Immunology. All rights reserved.","name":"copyright","label":"Copyright"}]}}